Ikarian Capital, LLC Pds Biotechnology Corp Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.05 - $6.68 $11,199 - $24,528	-3,672 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.78 - $8.43 $846 - $1,492	177 Added 5.06%	3,672 $22,000
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $27,121 - $50,153	3,495 New	3,495 $28,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $12.86 $1.67 Million - $4.93 Million	-383,373 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.28 - $6.81 $874,090 - $2.61 Million	383,373 New	383,373 $1.75 Million

4.32M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $62.6M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.